DaVita
DVA
#1391
Rank
A$19.34 B
Marketcap
$241.86
Share price
-1.26%
Change (1 day)
18.83%
Change (1 year)
DaVita Inc. is an American company providing dialysis services for patients with chronic and acute kidney failure.

Revenue for DaVita (DVA)

Revenue in 2024 (TTM): A$19.48 Billion

According to DaVita's latest financial reports the company's current revenue (TTM ) is A$21.41 Billion. an increase over the revenue in the year 2023 that were of A$17.81 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for DaVita from 1996 to 2024

20002005201020152020$5B$10B$15B$20B$25Bcompaniesmarketcap.com

Annual revenue

Year Revenue Change
2024 A$20.60 B15.63%
2023 A$17.81 B4.45%
2022 A$17.06 B6.45%
2021 A$16.02 B6.69%
2020 A$15.02 B-7.65%
2019 A$16.26 B0.47%
2018 A$16.18 B16.2%
2017 A$13.93 B-26.85%
2016 A$19.04 B0.67%
2015 A$18.91 B21%
2014 A$15.63 B18.54%
2013 A$13.18 B68.47%
2012 A$7.82 B17.29%
2011 A$6.67 B5.19%
2010 A$6.34 B-6.69%
2009 A$6.80 B-15.24%
2008 A$8.02 B33.24%
2007 A$6.02 B-2.75%
2006 A$6.19 B57.37%
2005 A$3.93 B32.45%
2004 A$2.97 B7.89%
2003 A$2.75 B-16.36%
2002 A$3.29 B1.77%
2001 A$3.23 B21.68%
2000 A$2.65 B20.88%
1999 A$2.19 B11.76%
1998 A$1.96 B145.51%
1997 A$0.80 B133.41%
1996 A$0.34 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
A$34.52 B 61.25%๐Ÿ‡บ๐Ÿ‡ธ USA
A$3.36 B-84.29%๐Ÿ‡บ๐Ÿ‡ธ USA
A$26.44 B 23.51%๐Ÿ‡บ๐Ÿ‡ธ USA
A$21.73 B 1.51%๐Ÿ‡บ๐Ÿ‡ธ USA